Skip to content

uniQure QURE Operating margin

Operating margin at other companies

Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-83.8%-3.0pp
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
-37,938%-37,986pp
PTC Therapeutics logo
PTC TherapeuticsPTCT
1.6%-38.7pp
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
-15,754.2%-17,253pp
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
42.8%+10.2pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-90.5%-41.2pp

Other financials

Income statement

See full
Revenue$3.6M+127%
Gross profit$3.3M+144%
Operating income-$45.7M-16.2%
Net income-$53.5M-22.7%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$140.0M-35.6%
Total debt$63.3M-4.3%
Total equity$149.3M+343%
Total assets$778.7M+28.6%

Cash flow

See full
Operating cash flow-$38.2M+13.3%
CapEx$140.0K+11.1%
Free cash flow-$38.4M+13.2%

Valuation

See full
Market cap$3.09B+78.4%
Enterprise value$3.02B+124%
P/S170.9×+85.1×

Profitability

See full
Gross margin90.6%-2.9pp
Net margin-1,154.4%+89.3pp
FCF margin-953.7%+169pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.4×-1.5×
Current ratio10.4×-1.6×

Where this comes from

Calculated from uniQure’s reported figures.

Based on trailing twelve months.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is uniQure's operating margin?
uniQure (QURE) reported operating margin of -1,059.7% in Q1 2026.
How has uniQure's operating margin changed year-over-year?
uniQure's operating margin decreased by 26.4% year-over-year, from -838.6% to -1,059.7%.
What is the long-term trend for uniQure's operating margin?
Over 4 years (2020 to 2025), uniQure's operating margin has grown at a 36.2% compound annual growth rate (CAGR), from -334.3% to -1,151.4%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.